Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Corey

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasisRobert L Vessella, Eva Corey
Cancer Letters|April 28, 2007
When prostate cancer meets bone: control by wntsKatayoon H Emami, Eva Corey
Frontiers in Oncology|June 7, 2018
Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate CancerHung-Ming Lam, Eva Corey
Methods in Molecular Biology (Clifton, N.J.)|July 29, 2011
Methodology to investigate androgen-sensitive and castration-resistant human prostate cancer xenografts in preclinical settingHolly M Nguyen, Eva Corey
The Journal of Urology|July 17, 2007
Bone morphogenetic proteins and prostate cancer: evolving complexitiesEva Corey, Robert L Vessella
Cancers|April 12, 2022
Proteomic and Transcriptomic Profiling Reveals Mitochondrial Oxidative Phosphorylation as Therapeutic Vulnerability in Androgen Receptor Pathway Active Prostate TumorsCaroline Xue, Eva Corey, Taranjit S Gujral
Current Cancer Drug Targets|March 12, 2009
Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayTodd M Morgan, Theodore D Koreckij, Eva Corey
The Prostate|May 15, 2003
A novel method of generating prostate cancer metastases from orthotopic implantsEva Corey, Janna E Quinn, Robert L Vessella
Nature Biomedical Engineering|April 25, 2019
Publisher Correction: A ribonucleoprotein octamer for targeted siRNA deliveryWanyi Tai, Junwei Li, Eva Corey, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2018
Generation of Prostate Cancer Patient-Derived Xenografts to Investigate Mechanisms of Novel Treatments and Treatment ResistanceHung-Ming Lam, Holly M Nguyen, Eva Corey
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasisRobert L Vessella, Eva Corey
Cancer Letters|April 28, 2007
When prostate cancer meets bone: control by wntsKatayoon H Emami, Eva Corey
Frontiers in Oncology|June 7, 2018
Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate CancerHung-Ming Lam, Eva Corey
Methods in Molecular Biology (Clifton, N.J.)|July 29, 2011
Methodology to investigate androgen-sensitive and castration-resistant human prostate cancer xenografts in preclinical settingHolly M Nguyen, Eva Corey
The Journal of Urology|July 17, 2007
Bone morphogenetic proteins and prostate cancer: evolving complexitiesEva Corey, Robert L Vessella
Cancers|April 12, 2022
Proteomic and Transcriptomic Profiling Reveals Mitochondrial Oxidative Phosphorylation as Therapeutic Vulnerability in Androgen Receptor Pathway Active Prostate TumorsCaroline Xue, Eva Corey, Taranjit S Gujral
Current Cancer Drug Targets|March 12, 2009
Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayTodd M Morgan, Theodore D Koreckij, Eva Corey
The Prostate|May 15, 2003
A novel method of generating prostate cancer metastases from orthotopic implantsEva Corey, Janna E Quinn, Robert L Vessella
Nature Biomedical Engineering|April 25, 2019
Publisher Correction: A ribonucleoprotein octamer for targeted siRNA deliveryWanyi Tai, Junwei Li, Eva Corey, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2018
Generation of Prostate Cancer Patient-Derived Xenografts to Investigate Mechanisms of Novel Treatments and Treatment ResistanceHung-Ming Lam, Holly M Nguyen, Eva Corey
Pageof 23